Clinical trial
Human Endogenous Retroviruses in Acute Myeloid Leukemia: Expression and Immune Impact
NCT04406207 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Endogenous Retroviruses in Acute Myeloid Leukemia: Expression and Immune Impact
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 1, 2020
- Completion date
- January 6, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.